medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Number 615

<< Back Next >>

Rev Med Cos Cen 2015; 72 (615)

Neuropatia óptica

Camacho EO, Gómez QA

Language: Spanish
References: 12
Page: 503-508
PDF size: 198.54 Kb.


ABSTRACT

There is a group of optic neuropathies of either genetic or acquired origin characterized by similar clinical manifestations with preferential involvement of the papillomacular bundle. These optic neuropathies share a presumed common pathophysiology of mitochondrial dysfunction. A variety of medications cause optic neuropathy by interfering with mitochondrial function. In many cases, drug toxicity is dose and duration dependent, and discontinuation of the drug can lead to significant visual recovery. Prompt recognition of this association is critical in preventing irreversible, profound visual loss.


REFERENCES

  1. Becker D, Balcer L, Galetta S. The neurological complications of nutritional deficiency following bariatric surgery. Journal of Obesity. 2012:608534.

  2. Carelli V, Ross-Cisneros F, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Progress in Retinal Eye Research. 2004; 23:53–89

  3. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochemistry International. 2002;40: 573–584

  4. Javaheri M, Khurana R, O’Hearn T. Linezolid‐induced optic neuropathy: a mitochondrial disorder?. British Journal Ophthalmology. 2007;91(1): 111–115.

  5. Kho R, Al-Obailan M, Arnold A. Bitemporal visual field defects in ethambutol-induced optic neuropathy. Journal of Neuroophthalmoly. 2011;31:121–126

  6. Kim U, Hwang J. Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography. European Journal of Ophthalmology 2009;19:466–469

  7. Miller N. Toxic and deficiency optic neuropathies. Clinical Neuroophthalmology, 2005:448–463.

  8. Pan B, Ross-Cisneros F, Carelli V, Rue K, Mathematically modeling the involvement of axons in Leber’s hereditary optic neuropathy. Investigative Ophthalmoly and Visual Science. 2012;53:608–617.

  9. Patrick Y., Philip G., Patrick F. Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies. Progress in Retinal and Eye Research. 2011; 30:81–114

  10. Rizzo J. Adenosine triphosphate deficiency: a genre of optic neuropathy. American Academy of Neurology. 1995;45:11–16

  11. Wong S, Silva F, Plant G. An old friend revisited: chloramphenicol optic neuropathy. JRSM Short Rep. Mar 2013; 4(3): 20.

  12. Yu-Wai-Man P, Griffiths P, Chinnery P. Mitochondrial optic neuropathies— disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30:81–114.




2020     |     www.medigraphic.com